Next Generation Sequencing Market Report 2021-2031
Global Next Generation Sequencing Market 2021-2031 – our new study reveals latest industry trends, R&D progress, and predicted revenues
Visiongain understands that the Global Next Generation Sequencing Market will register robust growth. Real time sequencing, portability and compatibility to other devices is expected to drive the NGS platform market by 2031. NGS Market is highly competitive with presence of well-established players with limited scope of regional manufacturers for sequencing platforms. Although, the sequencing services market will exhibit significant growth during the forecast period, with ever decreasing whole genome sequencing costs, thereby providing excellent commercial opportunities for new sequencing service providers worldwide.
Reagents & Consumables market valued XX million is set to grow at a CAGR of XX% from 2021-2031. Consumables & Reagents are crucial for conducting various steps of DNA or RNA sequencing. Many companies have their presence in this segment owing to high demand for kits and reagents. Most of the companies offer kits and reagents which are compatible for specific sequencing platform.
Bioinformatics has emerged as an important branch of NGS industry with many players venturing this segment to provide services such as data analytics, data management and data storage support for big research institutes, academics centers and mid-sized companies.
Application of sequencing for precision medicine and biomarker discovery is expected to drive the demand for sequencing services owing to growing incidence of cancer cases worldwide. Moreover, other applications such as prenatal screening and agriculture and animal genomics is expected to widen and expand the scope of NGS applications market. At the same time, lack of skilled labor force is expected to restrict the market growth.
North America continues to retain its hold on NGS market and accounts to have the largest market with presence of favourable government regulations, easy access to sequencing services along with relatively high insurance coverage across the region. The Asian region is expected to foresee the highest growth with companies such as BGI Genomics aggressively making its presence in global market. Our report keeps you informed and up to date with latest developments across geographies including North America, Europe, Asia, Latin America and Middle East and Africa.
The report also captures information pertaining to latest mergers & acquisitions, technological innovations, geographical expansion plans of all the leading players of this industry. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
The report provides in-depth information of key investment trends in global NGS market, subdivided by type of technology, services, platforms and applications.
This report includes data analysis and invaluable insight into how COVID-19 will affect your industry. Access this report today.
This report will answer questions such as:
- What is the NGS market status in 2020and how it will evolve through 2031?
- What are the drivers, restraints, and opportunities of the NGS market?
- How will each NGS submarket segment grow over the forecast period and how much revenue will each segment account for in 2031?
- How will individual leading national markets perform over the forecast period, and what are their drivers and restraints?
- What have been the major developments of the leading national markets for NGS market over recent years, leading to their current market status?
- How will the market shares of the regional and leading national markets evolve by 2031, and which geographical region will lead in 2031?
1) The Report provides NGS Market By Technology Forecast 2021-2031
- Sequencing By Synthesis
- Ion Semiconductor Sequencing
- Oxford Nanopore Sequencing
- Single Molecule Real Time Sequencing
- Products
- Services
- Illumina Sequencing Tools Market
- ThermoFischer Sequencing Tools Market
- Pacific Biosciences Tools Market
- Oxford Nanopore Sequencing Tools Market
- Other Sequencing Tools Market
- Sequencing Services
- Bioinformatics Services
- Whole Genome Sequencing
- Exome Sequencing
- Targeted Sequencing
- RNA Sequencing
- ChIP Sequencing
- De Novo Sequencing
- Methyl Sequencing
- Other Sequencing
- Drug Discovery
- Diagnostics
- Personalized Medicine
- Genetic Screening
- Infectious Diseases
- Agriculture & Animal Research
- Others
- Pharmaceutical Firms
- Biotech Firms
- Hospital & Diagnostics Centers
- Other Institutes
North America NGS Market
- US NGS Market
- Canada NGS Market
- Germany
- UK
- France
- Italy
- Spain
- Rest of Europe
- China
- India
- Japan
- Australia
- South Korea
- Rest of Asia
- Brazil
- Mexico
- Rest of Latin America
- GCC
- South Africa
- Rest of Latin America
9) The report provides detailed profiles of the leading companies operating within the NGS market:
- Agilent Technologies
- Beijing Genomics Institute
- Eurofins Scientific
- F. Hoffmann-La Roche
- Illumina Inc.,
- Macrogen
- Oxford Nanopore Technologies
- Pacific Biosciences of California Inc.,
- Perkin Elmer, Inc.
- Qiagen NV.,
- Thermo Fischer Scientific Inc.,
The publisher is using a password system to access all reports. Single user (non-printable) and departmental licenses expires after 12 month period. In the case of departmental site license purchases, the publisher requires all email addresses for the licensed users prior to fulfillment.
- 1. Report Overview
- 1.1 Introduction to NGS Market
- 1.2 NGS Market Definition
- 1.3 Why You Should Read This Report
- 1.4 What This Report Delivers
- 1.5 Key Questions Answered by This Analytical Report Include:
- 1.6 Who is This Report For?
- 1.7 Methodology
- 1.7.1 Primary Research
- 1.7.2 Secondary Research
- 1.7.3 Market Evaluation & Forecasting Methodology
- 1.7.3.1 Market Size Calculation
- 1.8 Frequently Asked Questions (FAQs)
- 1.9 Associated Visiongain Reports
- 1.10 About Visiongain
- 2 NGS Market: Executive Summary
- 3 NGS Market Dynamics
- 3.1 Introduction
- 3.2 Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Technologically Advanced Sequencing Platforms
- 3.2.2 Increasing Applications of NGS including COVID-19
- 3.2.3 Increasing Adoption of NGS Technologies Among Research & Academic Institutions
- 3.3 Market Restraint
- 3.3.1 Dearth of Skilled Professionals
- 3.3.2 Difficulties in Storage of Sequencing Data
- 3.4 Market Opportunity
- 3.4.1 Application of NGS in Precision Medicine & Biomarker Discovery
- 3.4.2 Integration of NGS platforms with Cloud Based Technology
- 3.4.3 Focus on Oncology Research
- 3.4.4 Growing number of Mergers & Acquisitions, Partnerships & Collaborations
- 3.5 SWOT Analysis
- 3.5.1 Strengths
- 3.5.2 Weaknesses
- 3.5.3 Opportunities
- 3.5.4 Threats
- 3.6 Porter’s Five Forces Analysis
- 3.6.1 Potential Threats from New Entrants (Low)
- 3.6.2 Potential Threat from Substitutes (Low)
- 3.6.3 Bargaining Power of Buyers (Low)
- 3.6.4 Rivalry High Among Existing Players
- 3.7 PEST Analysis
- 3.7.1 Political Factors Impacting NGS Market
- 3.7.2 Economic Factors Impacting NGS Market
- 3.7.3 Social Factors Impacting NGS Market
- 3.7.4 Technological Factors Impacting NGS Market
- 3.8 NGS Market: Value Chain Analysis
- 4 NGS Market by Technology Forecast, 2021-2031
- 4.1 SBS Technology a widely used technology whilst, Nanopore to grab the highest growth
- 4.2 NGS Market Outlook by Technology Type, 2021-2031: COVID Recovery Scenarios (V, U, W, L)
- 4.2 Sequencing by Synthesis (SBS) Technology Market Forecast, 2021-2031
- 4.2.1 SBS a well-established technology
- 4.2.2 SBS NGS Market Outlook for SBS Technology COVID Recovery Scenarios (V, U, W, L)
- 4.3 Ion Semiconductor Technology Market Forecast, 2021-2031
- 4.3.1 Ion Semiconductor sequencing will be instrumental for targeted sequencing
- 4.3.2 NGS Market Outlook for Ion Semiconductor Sequencing Market: COVID Recovery Scenarios (V, U, W, L)
- 4.4 SMRT Technology Market Forecast, 2021-2031
- 4.4.1 SMRT’s long reads in shorter time makes it a popular technology for R&D
- 4.4.2 NGS Market Outlook for SMRT Sequencing Market: COVID Recovery Scenarios (V, U, W, L)
- 4.5 Nanopore Technology Market Forecast, 2021-2031
- 4.5.1 Portability of devices with real time sequencing to make Nanopore Sequencing most lucrative technology
- 4.5.2 NGS Market Outlook for Nanopore Sequencing Market: COVID Recovery Scenarios (V, U, W, L)
- 4.6 Others Technology Market Forecast, 2021-2031
- 4.6.1 BGI to dominate the other sequencing technologies market
- 4.6.2 NGS Market Outlook for Others Sequencing Market: COVID Recovery Scenarios (V, U, W, L)
- 5 NGS Market by Products & Services Forecast, 2021-2031
- 5.1 Reagents & Consumables will continue to dominate the market by products
- 5.2 NGS Market Outlook by Products & Services Type, 2021-2031: COVID Recovery Scenarios (V, U, W, L)
- 6 NGS Market by Products Forecast, 2021-2031
- 6.1 Handheld and Real Time Sequencing Devices to drive the market growth
- 6.2 Illumina Sequencing Tools Market, 2021-2031
- 6.2.1 MiniSeq Systems
- 6.2.2 MiSeq Systems
- 6.2.3 NovaSeq Systems
- 6.2.4 iScan Systems
- 6.2.5 NextSeq System Series
- 6.3 ThermoFischer Sequencing Tools Market, 2021-2031
- 6.3.1 Ion PGM Systems
- 6.3.2. Ion Proton Systems
- 6.3.3 Ion GeneStudio S5 Systems
- 6.4 Pacific Biosciences Sequencing Tools Market, 2021-2031
- 6.4.1 PacBio RS II & IIe Systems
- 6.4.2 Sequel Systems
- 6.5 Oxford Nanopore Sequencing Tools Market, 2021-2031
- 6.5.1 PromethION
- 6.5.2 GridION
- 6.5.3 MinION
- 6.6 Other Sequencing Tools Market, 2021-2031
- 7. NGS Market by Reagents & Consumables, 2021-2031
- 7.1 Cost effective reagent kits to drive market growth of whole genome sequencing market
- 7.2 NGS Market Outlook for Reagents & Consumables Market: COVID Recovery Scenarios (V, U, W, L)
- 8. Global Next-Generation Sequencing Market By Services, 2021-2031
- 8.1 Bioinformatics poised as a strong opportunity for new entrants
- 8.1.1 NGS Market Outlook for Sequencing & Bioinformatics Services Market: COVID Recovery Scenarios (V, U, W, L)
- 8.2 Sequencing Services, By Types Market Forecast, 2021-2031
- 8.2.1 Global NGS Market Outlook for Sequencing Services, 2021-2031
- 8.2.2 NGS Market Outlook for Sequencing Services Market: COVID Recovery Scenarios (V, U, W, L)
- 9 NGS Market Outlook, By Sequencing Services Subtypes, 2021-2031
- 9.1 De Novo Sequencing & ChIP sequencing will be the forerunners for sequencing services market
- 9.2 Whole Genome Sequencing (WGS)
- 9.2.2 NGS Market Whole Genome Sequencing Services Market: COVID Recovery Scenarios (V, U, W, L)
- 9.3 Exome Sequencing
- 9.3.1 NGS Market Whole Genome Sequencing Services Market: COVID Recovery Scenarios (V, U, W, L)
- 9.4 Targeted Sequencing
- 9.4.1 NGS Market Targeted Sequencing Services Market: COVID Recovery Scenarios (V, U, W, L)
- 9.5 RNA Sequencing
- 9.4.1 NGS Market RNA Sequencing Services Market: COVID Recovery Scenarios (V, U, W, L)
- 9.6 ChIP Sequencing
- 9.4.1 NGS Market ChIP Sequencing Services Market: COVID Recovery Scenarios (V, U, W, L)
- 9.7 De Novo Sequencing
- 9.4.1 NGS Market De Novo Sequencing Services Market: COVID Recovery Scenarios (V, U, W, L)
- 9.8 Methyl Sequencing
- 9.4.1 NGS Market Methyl Sequencing Services Market: COVID Recovery Scenarios (V, U, W, L)
- 9.9 Other Sequencing
- 9.4.1 NGS Market Other Sequencing Services Market: COVID Recovery Scenarios (V, U, W, L)
- 10 NGS Market, By Applied Research, 2021-2031
- 10.1 Personalized Medicine to gain the highest market growth
- 10.2 Drug Discovery
- 10.2.1 NGS Market Drug Discovery Services Market: COVID Recovery Scenarios (V, U, W, L)
- 10.3 Diagnostics
- 10.3.1 NGS Market Diagnostics Market, By Applications: COVID Recovery Scenarios (V, U, W, L)
- 10.4 Personalized Medicine
- 10.4.1 NGS Market Personalized Medicine Services Market: COVID Recovery Scenarios (V, U, W, L)
- 10.5 Genetic Screening
- 10.5.1 NGS Market Genetic Screening Services Market: COVID Recovery Scenarios (V, U, W, L)
- 10.6 Infectious Diseases
- 10.6.1 NGS Market Infectious Diseases Services Market: COVID Recovery Scenarios (V, U, W, L)
- 10.7 Agriculture & Animal Research
- 10.7.1 NGS Market Agriculture & Animal Research Services Market: COVID Recovery Scenarios (V, U, W, L)
- 10.8 Others
- 10.8.1 NGS Market Others Services Market: COVID Recovery Scenarios (V, U, W, L)
- 11 NGS Market, By End Users, 2021-2031
- 11.1 Biotech & Pharmaceutical firms to drive the market with highest growth rate
- 11.1.1 NGS Market Outlook by End Users: COVID Recovery Scenarios (V, U, W, L)
- 11.2 Academic Research & Government Institutes
- 11.2.1 NGS Market Outlook for Academic Research & Government Institutes: COVID Recovery (V, U, W, L)
- 11.3 Pharmaceutical Companies
- 11.3.2 NGS Market Outlook for Pharmaceutical & Biotechnology Companies: COVID Recovery Scenarios (V, U, W, L)
- 11.3 Hospitals & Diagnostics Centers
- 11.3.3 NGS Market Outlook for Hospitals & Diagnostic Centers: COVID Recovery Scenarios (V, U, W, L)
- 11.4 Biotech Institutes
- 11.4.1 NGS Market Outlook for Biotech Institutes: COVID Recovery Scenarios (V, U, W, L)
- 11.4 Other Institutes
- The Other Institutes includes cancer research institutes, forensic laboratories and agricultural and animal research institutes.
- 11.4.2 NGS Market Outlook for Other Institutes: COVID Recovery Scenarios (V, U, W, L)
- 12 Regional NGS Market Forecasts 2021-2031
- 12.1 The Asian region to seize the highest growth during the forecast study
- 12.2 NGS Market Outlook by Region: COVID Recovery Scenarios (V, U, W, L)
- 13 North America NGS Market Forecasts 2021-2031
- 13.1 Canada poised to have high growth rate owing to significant funding and biotech hubs
- 13.2 North America NGS Market Outlook: COVID Recovery Scenarios (V, U, W, L)
- 13.3 North America NGS Market Outlook, By Technology
- 13.3.1 North America NGS Market Outlook, By Technology: COVID Recovery Scenarios (V, U, W, L)
- 13.4 North America NGS Market Outlook, By Products & Services
- 13.4.1 North America NGS Market Outlook, By Products & Services: COVID Recovery Scenarios (V, U, W, L)
- 13.4 North America NGS Market Outlook, By End Users
- 13.4.2 North America NGS Market Outlook, By End Users: COVID Recovery Scenarios (V, U, W, L)
- 13.5 North America NGS Market Outlook, By Services
- 13.5.2 North America NGS Market Outlook, By Services: COVID Recovery Scenarios (V, U, W, L)
- 13.6 North America NGS Market Outlook, By Sequencing Services
- 13.6.1 North America NGS Market Outlook, By Sequencing Services: COVID Recovery Scenarios (V, U, W, L)
- 13.7 US
- 13.7.1 US will continue its dominance on NGS market owing to significant funding from the Government
- 13.7.1 US will continue to be the major hub for Innovative companies
- 13.5.2 US NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 13.8 Canada
- 13.8.1 Canada Emerging as a Major Biotech hub of North America
- 13.8.2 Canada strengthens its Genome and Bioinformatics research through funding and collaborations
- 13.8.3 Canada NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 14 Europe NGS Market Forecasts 2021-2031
- 14.1 Presence of many Biotech & Sequencing firms reinforces the NGS market growth in Europe
- 14.2 Europe NGS Market Outlook: COVID Recovery Scenarios (V, U, W, L)
- 14.3 Europe NGS Market Outlook, By Technology
- 14.3.1 Europe NGS Market Outlook, By Technology: COVID Recovery Scenarios (V, U, W, L)
- 14.4 Europe NGS Market Outlook, By Products & Services
- 14.4.2 Europe NGS Market Outlook, By Products & Services: COVID Recovery Scenarios (V, U, W, L)
- 14.5 Europe NGS Market Outlook, By End Users
- 14.5.2 Europe NGS Market Outlook, By End Users: COVID Recovery Scenarios (V, U, W, L)
- 14.6 Europe NGS Market Outlook, By Services
- 14.6.1 Europe NGS Market Outlook, By Services: COVID Recovery Scenarios (V, U, W, L)
- 14.7 Europe NGS Market Outlook, By Sequencing Services
- 14.7.2 Europe NGS Market Outlook, By Sequencing Services: COVID Recovery Scenarios (V, U, W, L)
- 14.8 Germany
- 14.8.1 German Government supports Biotech Research through formation of CRCs consequently boosting NGS growth
- 14.8.2 Lack of Legal Framework Hampering Genomic Research
- 14.8.3 Germany NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 14.9 UK
- 14.9.1 UKs Public Private Partnerships to support Cancer & Rare Genetic Diseases
- 14.9.2 Illumina opens Illumina Accelerator in Cambridge to support start ups
- 14.9.3 UK NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 14.10 France
- 14.10.1 France Designates Biotech Industry as Nation’s Research Priority
- 14.10.2 French Government supportive of collaborative biotech research
- 14.10.3 France NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 14.11 Italy
- 14.11.1 Italian Government pursues to be on forefront in precision medicine
- 14.11.2 Italian Government supports growth of small and mid-sized biotech companies through innovation incubators
- 14.11.3 Italy NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 14.12 Spain
- 14.12.1 Spanish Government to support precision medicine through funding of US$29.5 million
- 14.12.2 Evidence based and disruptive technologies to receive support through Government funding
- 14.12.3 Spain NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 14.13 Rest Of Europe (ROE)
- 14.13.1 Genetic landscaping helping companies to identify causative factors
- 14.13.2 More sequencing companies emerging in ROE region
- 14.12.3 Rest Of Europe NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 15 Asia NGS Market Forecasts 2021-2031
- 15.1 India and China to hold the baton for NGS growth in Asian region
- 15.2 Asia NGS Market Outlook: COVID Recovery Scenarios (V, U, W, L)
- 15.3 Asia NGS Market Outlook, By Technology
- 15.3.1 Asia NGS Market Outlook, By Technology: COVID Recovery Scenarios (V, U, W, L)
- 15.4 Asia NGS Market Outlook, By Products & Services
- 15.4.1 Asia NGS Market Outlook, By Products & Services: COVID Recovery Scenarios (V, U, W, L)
- 15.5 Asia NGS Market Outlook, By End Users
- 15.5.1 Asia NGS Market Outlook, By End Users: COVID Recovery Scenarios (V, U, W, L)
- 15.6 Asia NGS Market Outlook, By Services
- 15.6.1 Asia NGS Market Outlook, By Services: COVID Recovery Scenarios (V, U, W, L)
- 15.7 Asia NGS Market Outlook, By Sequencing Services
- 15.7.1 Asia NGS Market Outlook, By Sequencing Services: COVID Recovery Scenarios (V, U, W, L)
- 15.8 China
- 15.8.1 China to seize the market growth owing to rise in adoption of transcriptomics for biotech R&D
- 15.8.2 China expanding its global presence through acquisition, collaborations & partnership including technological innovations
- 15.8.2 China NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 15.9 India
- 15.9.1 Initiatives such as “Make In India” and “Start-up India” undertaken by Indian Government to support biotech growth
- 15.9.2 Significant funding to support the market growth
- 15.9.3 India NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 15.10 Japan
- 15.10.1 Japan supports genomic research through inclusion of genomic medicine under its health insurance programs
- 15.10.2 Japanese companies collaborate with international firms and universities
- 15.10.3 Japan NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 15.11 Australia
- 15.11.1 Robust R&D coupled with strong government support to boost the market growth
- 15.11.2 Country’s own genetic sequencer
- 15.11.3 Australia NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 15.12 South Korea
- 15.12.1 South Korea attracting FDIs through development of Biotech Clusters
- 15.12.2 South Korea using genetic mapping for precision medicine
- 15.12.3 S. Korea NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 15.13 Rest of Asia
- 15.13.1 Countries in APAC receiving funding from pharma companies to develop skilled labour
- 15.13.2 Tax Exemption one of the strategies to attract new companies
- 15.12.3 Rest of Asia NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 16 Latin America NGS Market Forecasts 2021-2031
- 16.1 Simplified Regulatory Requirements and Cost effective services drawing attention of major players
- 16.2 Latin America NGS Market Outlook: COVID Recovery Scenarios (V, U, W, L)
- 16.3 Latin America NGS Market Outlook, By Technology
- 16.3.1 Latin America NGS Market Outlook, By Technology: COVID Recovery Scenarios (V, U, W, L)
- 16.4 Latin America NGS Market Outlook, By Products & Services
- 16.4.2 Latin America NGS Market Outlook, By Products & Services: COVID Recovery Scenarios (V, U, W, L)
- 16.5 Latin America NGS Market Outlook, By End Users
- 16.5.2 Latin America NGS Market Outlook, By End Users: COVID Recovery Scenarios (V, U, W, L)
- 16.6 Latin America NGS Market Outlook, By Services
- 16.6.1 Latin America NGS Market Outlook, By Services: COVID Recovery Scenarios (V, U, W, L)
- 16.7 Latin America NGS Market Outlook, By Sequencing Services
- 16.7.2 Latin America NGS Market Outlook, By Sequencing Services: COVID Recovery Scenarios (V, U, W, L)
- 16.8 Brazil
- 16.8.1 Although rise in pharmaceutical companies, genetic sequencing market has witnessed slow growth
- 16.8.2 Uptake of prenatal screening is on rise however, other test need access to tertiary care centers
- 16.8.3 Brazil NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 16.9 Mexico
- 16.9.1 Mexico leveraging its strategic location to attract investments in the country
- 16.8.2 Mexico’s Public Funding to improve skilled labor required for genomic research
- 16.8.3 Mexico NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 16.10 Rest of Latin America (ROLA)
- 16.10.1 Rest of Latin America to witness slow and gradual growth
- 16.10.2 Presence of multinational pharmaceutical companies is expected to open new avenues for NGS market
- 16.8.3 Rest Of Latin America NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 17 Middle East & Africa NGS Market Forecasts 2021-2031
- 17.1 MEA NGS Market is still an unexplored territory for many pharma companies
- 17.2 Middle East & Africa NGS Market Outlook: COVID Recovery Scenarios (V, U, W, L)
- 17.3 Middle East & Africa NGS Market Outlook, By Technology
- 17.3.1 Middle East & Africa NGS Market Outlook, By Technology: COVID Recovery Scenarios (V, U, W, L)
- 17.4 Middle East & Africa NGS Market Outlook, By Products & Services
- 17.4.2 Middle East & Africa NGS Market Outlook, By Products & Services: COVID Recovery Scenarios (V, U, W, L)
- 17.5 Middle East & Africa NGS Market Outlook, By End Users
- 17.5.2 Middle East & Africa NGS Market Outlook, By End Users: COVID Recovery Scenarios (V, U, W, L)
- 17.6 Middle East & Africa NGS Market Outlook, By Services
- 17.6.1 Middle East & Africa NGS Market Outlook, By Services: COVID Recovery Scenarios (V, U, W, L)
- 17.7 Middle East & Africa NGS Market Outlook, By Sequencing Services
- 17.7.2 Middle East & Africa NGS Market Outlook, By Sequencing Services: COVID Recovery Scenarios (V, U, W, L)
- 17.8 GCC
- 17.8.1 Government collaborations with International companies to bring advanced technology in the country
- 17.8.2 Sidra Medicine opened three core laboratories in Qatar for translational research
- 17.8.3 GCC NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 17.9 South Africa
- 17.9.1 South African Health Regulatory Authority to support the growth of pharmaceutical sector
- 17.9.2 Genome Center established in Cape Town
- 17.9.3 South Africa NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 17.10 Rest of Middle East & Africa
- 17.10.1 Lack of comprehensive education and lack of skilled workforce is restricting the growth in this region
- 17.8.3 Rest of Middle East & Africa NGS Market Outlook, By COVID Recovery Scenarios (V, U, W, L)
- 18 Company Profiles
- 18.1 Company Share Analysis
- 18.2 Recent Developments of NGS Market
- 18.3 Agilent Technologies Inc.,
- 18.3.1 Company Snapshot
- 18.3.2 Company Overview
- 18.3.3 Future Outlook
- 18.3.4 Financial Analysis
- 18.3.4.1 Net Revenues,2016-2019
- 18.3.4.2 Regional Market Share, 2019
- 18.3.4.3 Business Segment Market Share, 2019
- 18.3.4.4 Product/Services Market Share, 2019
- 18.3.5 Product Benchmarking
- 18.3.6 Recent Developments
- 18.4 Illumina Ic.,
- 18.4.1 Company Snapshot
- 18.4.2 Company Overview
- 18.4.3 Future Outlook
- 18.4.4 Financial Analysis
- 18.4.4.1 Net Revenues,2016-2019
- 18.4.4.2 Regional Revenues, 2019
- 18.4.4.3 Business Segmental Revenues, 2019
- 18.4.4.4 Sales, By Type,2019
- 18.4.5 Product Benchmarking
- 18.4.6 Recent Developments
- 18.5 Qiagen NV,
- 18.5.1 Company Snapshot
- 18.5.2 Company Overview
- 18.5.3 Future Outlook
- 18.5.4 Financial Analysis
- 18.5.4.1 Net Revenues,2016-2019
- 18.5.4.2 Regional Revenues, 2019
- 18.5.4.3 Segmental Revenues, 2019
- 18.5.4.4 Sales, By Type,2019
- 18.5.5 Product Benchmarking
- 18.5.6 Recent Developments
- 18.6 F. Hoffmann-La Roche Ltd,
- 18.6.1 Company Snapshot
- 18.6.2 Company Overview
- 18.6.3 Future Outlook
- 18.6.4 Financial Analysis
- 18.6.4.1 Net Revenues,2016-2019
- 18.6.4.2 Regional Revenues, 2019
- 18.6.4.3 Segmental Revenues, 2019
- 18.6.4.4 Sales, By Type,2019
- 18.6.5 Product Benchmarking
- 18.6.6 Recent Developments
- 18.7 Thermo Fischer Scientific Inc.,
- 18.7.1 Company Snapshot
- 18.7.2 Company Overview
- 18.7.3 Future Outlook
- 18.7.4 Financial Analysis
- 18.7.4.1 Net Revenues,2016-2019
- 18.7.4.2 Regional Revenues, 2019
- 18.7.4.3 Segmental Revenues, 2019
- 18.7.4.4 Sales, By Type,2019
- 18.7.5 Product Benchmarking
- 18.7.6 Recent Developments
- 18.8 Pacific Biosciences of California Inc.,
- 18.8.1 Company Snapshot
- 18.8.2 Company Overview
- 18.8.3 Future Outlook
- 18.8.4 Financial Analysis
- 18.8.4.1 Net Revenues,2016-2019
- 18.8.4.2 Regional Revenues, 2019
- 18.8.4.3 Segmental Revenues, 2019
- 18.8.4.4 Sales, By Type,2019
- 18.8.5 Product Benchmarking
- 18.8.6 Recent Developments
- 18.9 Oxford Nanopore Technologies, Ltd
- 18.9.1 Company Snapshot
- 18.9.2 Company Overview
- 18.9.3 Future Outlook
- 18.9.4 Financial Analysis
- 18.9.5 Product Benchmarking
- 18.9.6 Recent Developments
- 18.10 Macrogen, Inc.,
- 18.10.1 Company Snapshot
- 18.10.2 Company Overview
- 18.10.3 Future Outlook
- 18.10.4 Financial Analysis
- 18.10.5 Product Benchmarking
- 18.10.6 Recent Developments
- 18.11 Eurofins Scientific.
- 18.11.1 Company Snapshot
- 18.11.2 Company Overview
- 18.11.3 Future Outlook
- 18.11.4 Financial Analysis
- 18.11.4.1 Net Revenues,2016-2019
- 18.11.4.2 Regional Revenues, 2019
- 18.11.4.3 Segmental Revenues, 2019
- 18.11.5 Product Benchmarking
- 18.11.6 Recent Developments
- 18.12 BGI (Beijing Genomics Institute)
- 18.12.1 Company Snapshot
- 18.12.2 Company Overview
- 18.12.3 Future Outlook
- 18.12.4 Financial Analysis
- 18.12.5 Product Benchmarking
- 18.12.6 Recent Developments
- 18.13 Perkin Elmer, Inc.
- 18.13.1 Company Snapshot
- 18.13.2 Company Overview
- 18.13.3 Future Outlook
- 18.13.4 Financial Analysis
- 18.13.4.1 Net Revenues,2016-2019
- 18.13.4.2 Regional Revenues, 2019
- 18.13.4.3 Segmental Revenues, 2019
- 18.13.5 Product Benchmarking
- 18.13.6 Recent Developments
- 19. Conclusion & Recommendations
- 19.1 Concluding Remarks from Visiongain
- 19.2 Recommendation for Market Players
- 19.3 Leading Regions and Fastest Growing Region
- 19.3.1 North America will continue to have its lion’s share during forecast period.
- 19.3.2 India and China to drive the NGS growth in Asian Pacific region
- List of Tables
- Table 1 Global NGS Market Snapshot, 2021 & 2031 (USD Million, CAGR %)
- Table 2 NGS Market, 2021-2031 (USD Million, AGR %, CAGR %)
- Table 3 Global NGS Market, Partnership & Collaborations, 2019-2021
- Table 2 NGS Market Size by Technology Type, 2021-2031 (USD Million, AGR %, CAGR %)
- Table 3 NGS Market Size by Technology Type, 2021-2031 (USD Million, AGR %, CAGR %): V Shaped Recovery)
- Table 4 NGS Market Size by Technology Type, 2021-2031 (USD Million, AGR %, CAGR %): U Shaped Recovery
- Table 5 NGS Market Size by Technology Type, 2021-2031 (USD Million, AGR %, CAGR %): L Shaped Recovery
- Table 6 NGS Market Size by Technology Type, 2021-2031 (USD Million, AGR %, CAGR %): W Shaped Recovery)
- Table 7 NGS Technology Market , Sequencing By Synthesis (SBS) Market, By Technology 2021-2031 (USD Million, AGR %, CAGR %)
- Table 8 NGS Sequencing By Synthesis (SBS) Market, By Technology 2021-2031 (USD Million, AGR %, CAGR %) V Shaped Recovery
- Table 9 NGS Sequencing By Synthesis (SBS) Market, By Technology 2021-2031 (USD Million, AGR %, CAGR %: U Shaped Recovery
- Table 10 NGS Market for SBS Technology Market, 2021-2031 (USD Million, AGR %, CAGR %): L Shaped Recovery
- Table 11 NGS Market for SBS Technology Market, 2021-2031 (USD Million, AGR %, CAGR %): W Shaped Recovery
- Table 12 NGS Market By Technology, Ion Semiconductor Sequencing Market,( Revenue US $ million, AGR%, CAGR%), 2021-2031
- Table 13 NGS Market Ion Semiconductor Sequencing Market,( Revenue US $ million, AGR%, CAGR%), 2021-2031: V Shaped Recovery
- Table 14 NGS Market for Ion Semiconductor Sequencing Market,( Revenue US $ million, AGR%, CAGR%), 2021-2031: U Shaped Recovery
- Table 15 NGS Market for Ion Semiconductor Sequencing Market,( Revenue US $ million, AGR%, CAGR%), 2021-2031: L Shaped Recovery
- Table 16 NGS Market for Ion Semiconductor Sequencing Market,( Revenue US $ million, AGR%, CAGR%), 2021-2031: W Shaped Recovery
- Table 17 NGS Market for SMRT Technology, 2021-2031 (USD Million, AGR %, CAGR %)
- Table 18 NGS Market for SMRT Technology, 2021-2031 (USD Million, AGR %, CAGR %): V Shaped Recovery
- Table 19 NGS Market for SMRT Technology, 2021-2031 (USD Million, AGR %, CAGR %): U Shaped Recovery
- Table 20 NGS Market for SMRT Technology Market Value Forecast, 2021– 2031 (USD Million, AGR %): L Shaped Recovery
- Table 21 NGS Market for SMRT Technology, 2021-2031 (USD Million, AGR %, CAGR %): W Shaped Recovery
- Table 22 NGS Market for Nanopore Technology, 2021-2031 (USD Million, AGR %, CAGR %)
- Table 23 NGS Market for Nanopore Technology, 2021-2031 (USD Million, AGR %, CAGR %): V Shaped Recovery
- Table 24 NGS Market for Nanopore Technology, 2021-2031 (USD Million, AGR %, CAGR %): U Shaped Recovery
- Table 25 NGS Market for Nanopore Technology Market Value Forecast, 2021-2031 (USD Million, AGR %): L Shaped Recovery
- Table 26 NGS Market for Nanopore Technology, 2021-2031 (USD Million, AGR %, CAGR %): W Shaped Recovery
- Table 27 NGS Market for Others Technology, 2021-2031 (USD Million, AGR %, CAGR %)
- Table 28 NGS Market for Others Technology, 2021-2031 (USD Million, AGR %, CAGR %): V Shaped Recovery
- Table 29 NGS Market for Others Technology, 2021-2031 (USD Million, AGR %, CAGR %): U Shaped Recovery
- Table 30 NGS Market for Others Technology Market Value Forecast, 2021-2031 (USD Million, AGR %): L Shaped Recovery
- Table 31 NGS Market for Others Technology, 2021-2031 (USD Million, AGR %, CAGR %): W Shaped Recovery
- Table 32 NGS Market Size by Technology Type, 2021-2031 (USD Million, AGR %, CAGR %)
- Table 33 NGS Market Size by Products & Services Type, 2021-2031 (USD Million, AGR %, CAGR %): V Shaped Recovery)
- Table 34 Global NGS Market Size by Products & Services, 2021-2031 (USD Million, AGR %): U Shaped Recovery
- Table 35 NGS Market Size by Products & Services Type, 2021-2031 (USD Million, AGR %, CAGR %): L Shaped Recovery
- Table 36 NGS Market Size by Products & Services Type, 2021-2031 (USD Million, AGR %, CAGR %): W Shaped Recovery)
- Table 37 Global NGS Sequencing Tools Market, 2021-2031 (USD mn, AGR%, CAGR%)
- Table 38 Illumina Sequencing Tools Market, 2021-2031 (USD Million, AGR %, CAGR %)
- Table 39 ThermoFischer Sequencing Tools Market, 2021-2031 (USD Million, AGR %, CAGR %)
- Table 39 Pacific Biosciences Sequencing Tools Market, 2021-2031 (USD Million, AGR %, CAGR %)
- Table 39 Oxford Nanopore Sequencing Tools Market, 2021-2031 (USD Million, AGR %, CAGR %)
- Table 40 Other Sequencing Tools Market, 2021-2031 (USD Million, AGR %, CAGR %)
- Table 41 Global NGS Market Size for Reagents & Consumables, 2021-2031 (USD Million, AGR %, CAGR %)
- Table 39 NGS Market Size for Reagents & Consumables, 2021-2031 (USD Million, AGR %, CAGR %): V Shaped Recovery
- Table 40 NGS Market Size for Reagents & Consumables, 2021-2031 (USD Million, AGR %, CAGR %): U Shaped Recovery
- Table 41 NGS Market Size for Reagents & Consumables, 2021-2031 (USD Million, AGR %, CAGR %): L Shaped Recovery
- Table 42 NGS Market Size for Reagents & Consumables, 2021-2031 (USD Million, AGR %, CAGR %): W Shaped Recovery
- Table 41 NGS Sequencing Market Size by Type of Sequencing & Bioinformatics Services, 2021– 2031 (USD Million, AGR %, CAGR %)
- Table 43 NGS Market for Sequencing & Bioinformatics Services, 2021-2031 (USD Million, AGR %, CAGR %): V Shaped Recovery
- Table 44 NGS Market for Sequencing & Bioinformatics Services, 2021-2031 (USD Million, AGR %, CAGR %): U Shaped Recovery
- Table 45 NGS Market for Sequencing & Bioinformatics Services, 2021-2031 (USD Million, AGR %, CAGR %): L Shaped Recovery
- Table 46 NGS Market for Sequencing Services & Bioinformatics, 2021-2031 (USD Million, AGR %, CAGR %): W Shaped Recovery
- Table 41 NGS Sequencing Market Size by Type of Services, 2021-2031 (USD Million, AGR %, CAGR %)
- Table 47 NGS Sequencing Market Size by Type of Services, 2021– 2031 (USD Million, AGR %, CAGR %): V Shaped Recovery
- Table 48 Global NGS Market Size by Sequencing Services, Sequencing 2021-2031 (USD Million, AGR %) U Shaped Recovery
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook